Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure
Canadian Journal of Physiology and Pharmacology · 01.02.2024 · 102 (2) · 86-104
DOI: 10.1139/cjpp-2023-0226 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Journal of Physiology and Pharmacology, erschienen am 01.02.2024. Verfasst von Sukhwinder K Bhullar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre and Department of Physiology and Pathophysiology, Max Rady Co…. Hauptthemen laut MEDLINE: Receptors, Angiotensin, Heart Failure. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 300 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Angiotensin II (Ang II) is formed by the action of angiotensin-converting enzyme (ACE) in the renin–angiotensin system. This hormone is known to induce cardiac hypertrophy and heart failure and its actions are mediated by the interaction of both pro- and antihypertrophic Ang II receptors (AT1R and AT2R). Ang II is also metabolized by ACE 2 to Ang-(1–7), which elicits the activation of Mas receptors (MasR) for inducing antihypertrophic actions. Since heart failure under different pathophysiological situations is preceded by adaptive and maladaptive cardiac hypertrophy, we have reviewed the existing literature to gain some information regarding the roles of AT1R, AT2R, and MasR in both acute and chronic conditions of cardiac hypertrophy. It appears that the activation of AT1R may be involved in the development of adaptive and maladaptive cardiac hypertrophy as well as subsequent heart failure because both ACE inhibitors and AT1R antagonists exert beneficial effects. On the other hand, the activation of both AT2R and MasR may prevent the occurrence of maladaptive cardiac hypertrophy and delay the progression of heart failure, and thus therapy with different activators of these antihypertrophic receptors under chronic pathological stages may prove beneficial. Accordingly, it is suggested that a great deal of effort should be made to develop appropriate activators of both AT2R and MasR for the treatment of heart failure subjects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre and Department of Physiology and Pathophysiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.
ORCID-Profile: Naranjan S Dhalla
Zitieren
APA
Bhullar, S. K., & Dhalla, N. S. (2024). Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure. Canadian Journal of Physiology and Pharmacology, 102(2), 86-104. https://doi.org/10.1139/cjpp-2023-0226
Vancouver
Bhullar SK, Dhalla NS. Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure. Canadian Journal of Physiology and Pharmacology. 2024;102(2):86-104. doi:10.1139/cjpp-2023-0226
BibTeX
@article{Bhullar2024,
author = {Bhullar, Sukhwinder K and Dhalla, Naranjan S},
title = {Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2024},
volume = {102},
number = {2},
pages = {86--104},
doi = {10.1139/cjpp-2023-0226}
}
EUVIMED